Remove 2019 Remove Communication Remove Compounding
article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

billion in 2022 and is expected to grow at a compound annual growth rate of 5.3% Simplified Communication and Coordination : Integrated CDMOs can improve cross-team coordination between research, development, and manufacturing, reducing the need for external hand-offs, technology transfer, and knowledge dissemination. .”

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Extemporaneous Preparation with Unknown Stability

RX Note

Today, stability information can be obtained from manufacturer’s labelling information (such as in the package insert), the USP compounding monographs, or peer-reviewed articles and references , such as articles in American Journal of Health-System Pharmacy, the International Journal of Pharmaceutical Compounding.

article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. compared with 2019, and the digital spend is forecast to increase to $11.25 The global outbreak of COVID-19 has forced businesses to radically change their way of working.

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Amsterdam: Gupta Strategists; 2019. About the author. References. European Commission.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. However, 2019 saw Eli Lilly respond to criticism of high insulin prices by launching a cut-price version. Between December 1, 2018 and January 31, 2019, 65% of erectile dysfunction prescriptions filled were for Viagra or its generic version 12.

article thumbnail

Medication Safety

RX Note

Such events may be related to professional practice and healthcare products, procedures and systems, including prescribing; order communication; product labelling, packaging and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use.